Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 仁和药业股份有限公司是一家以制造OTC药品,同时销售OTC药品、健康相关产品为主业.包括胶囊剂、颗粒剂、片剂、栓剂、软膏剂、搽剂等药品以及健康相关产品的公司.公司主要产品:仁和可立克、优卡丹、达舒克等.通过"仁和"品牌不断提升上市公司新的形象,将上市公司塑造成可持续发展的综合性医药企业.公司已建立较完善的公司治理结构与内部控制体系,为提高业务运营水平、提高精细化管理水平奠定了良好的基础。
Main Business 生产、销售中西药、原料药及健康相关产品，包括口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂等剂型药品以及健康相关产品。
Legal Representative 杨潇
Top Executives
董事长：杨潇
副董事长：肖正连
董事：张自强,黄武军,杨潇,彭秋林,姜锋
独立董事：涂书田,王跃生,郭亚雄
Top 5 Shareholder
Shareholder name Nature Holding Date
仁和（集团）发展有限公司流通A股23.24%31/03/2024
杨潇限售股+流通A股6.53%31/03/2024
香港中央结算有限公司流通A股1.16%31/03/2024
中国工商银行股份有限公司－广发稳健回报混合型证券投资基金流通A股0.98%31/03/2024
中国银行股份有限公司－广发医疗保健股票型证券投资基金流通A股0.93%31/03/2024
Company Secretary 姜锋
Solicitors 江西求正沃德律师事务所
Auditors 大华会计师事务所（特殊普通合伙）
Tel No 0791-83896755
Fax No 0791-83896755
Website www.renheyaoye.com
Email rh000650@126.com
Company Address
Register: 江西省樟树市葛玄路6号
Office: 江西省南昌市红谷滩新区红谷中大道998号绿地中央广场B区元创国际18层
Listing Date 10/12/1996
Shares Capital
Shares Capital: 1,399,938,234
Total A Share: 1,399,938,234
Listed A Share: 1,331,385,834
Non-tradable A Share: 68,552,400
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.410
DPS(RMB)* ¥ 0.200
NBV Per Share(RMB)* ¥ 4.281
Market Capitalization(RMB) 9.493B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.